AcelRx Pharmaceuticals Inc (NASDAQ:ACRX)

2.30
Delayed Data
As of 4:00pm ET
 -0.05 / -2.13%
Today’s Change
1.55
Today|||52-Week Range
5.75
+13.58%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$105.7M

Company Description

AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company, which is engaged in the development and commercialization of innovative therapies for the treatment of acute pain. Its products are DSUVIA, and ZALVISO. The company was founded by Thomas A. Schreck and Pamela P. Palmer on July 13, 2005 and is headquartered in Redwood City, CA.

Contact Information

AcelRx Pharmaceuticals, Inc.
351 Galveston Drive
Redwood City California 94063
P:(650) 216-3500
Investor Relations:

Employees

Shareholders

Other institutional4.94%
Mutual fund holders4.49%
Individual stakeholders22.13%

Top Executives

Vincent J. AngottiChief Executive Officer & Director
Raffi AsadorianChief Financial Officer
Pamela Pierce PalmerDirector & Chief Medical Officer
Jane Wright-MitchellSecretary, Chief Legal & Compliance Officer
Lawrence G. HamelChief Development Officer